Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M-ACCEL: HU6 in Nonalcoholic Steatohepatitis
NCT05979779Phase 2Active, not recruiting
- Sponsor
- Rivus Pharmaceuticals, Inc.
- Start
- Sep 2023
- Primary completion
- Jan 2025
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HU6 in Nonalcoholic steatohepatitis (NASH), sponsored by Rivus Pharmaceuticals, Inc.. Started Sep 2023; status: active, not recruiting.
02
Drugs
HU6
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05979779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05979779.